NCT05287464 2025-11-26
International Multicentric Study ARON-1
Hospital of Macerata
Recruiting
Clinical Trials
4 trialsNCT06345183 2025-11-06
Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients
Bristol-Myers Squibb
Completed
NCT06421311 2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown